ACADIA Pharmaceuticals (ACAD) Competitors $20.52 -1.22 (-5.60%) As of 03:38 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock ACAD vs. ASND, VTRS, RDY, ROIV, MRNA, QGEN, BBIO, ELAN, VRNA, and RVMDShould you be buying ACADIA Pharmaceuticals stock or one of its competitors? The main competitors of ACADIA Pharmaceuticals include Ascendis Pharma A/S (ASND), Viatris (VTRS), Dr. Reddy's Laboratories (RDY), Roivant Sciences (ROIV), Moderna (MRNA), Qiagen (QGEN), BridgeBio Pharma (BBIO), Elanco Animal Health (ELAN), Verona Pharma PLC American Depositary Share (VRNA), and Revolution Medicines (RVMD). These companies are all part of the "pharmaceutical products" industry. ACADIA Pharmaceuticals vs. Its Competitors Ascendis Pharma A/S Viatris Dr. Reddy's Laboratories Roivant Sciences Moderna Qiagen BridgeBio Pharma Elanco Animal Health Verona Pharma PLC American Depositary Share Revolution Medicines ACADIA Pharmaceuticals (NASDAQ:ACAD) and Ascendis Pharma A/S (NASDAQ:ASND) are both medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their earnings, profitability, dividends, institutional ownership, valuation, analyst recommendations, risk and media sentiment. Do analysts rate ACAD or ASND? ACADIA Pharmaceuticals presently has a consensus target price of $29.12, suggesting a potential upside of 40.36%. Ascendis Pharma A/S has a consensus target price of $248.29, suggesting a potential upside of 18.85%. Given ACADIA Pharmaceuticals' higher possible upside, research analysts plainly believe ACADIA Pharmaceuticals is more favorable than Ascendis Pharma A/S.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score ACADIA Pharmaceuticals 1 Sell rating(s) 6 Hold rating(s) 12 Buy rating(s) 1 Strong Buy rating(s) 2.65Ascendis Pharma A/S 1 Sell rating(s) 0 Hold rating(s) 15 Buy rating(s) 0 Strong Buy rating(s) 2.88 Which has more volatility and risk, ACAD or ASND? ACADIA Pharmaceuticals has a beta of 0.75, suggesting that its share price is 25% less volatile than the S&P 500. Comparatively, Ascendis Pharma A/S has a beta of 0.41, suggesting that its share price is 59% less volatile than the S&P 500. Which has preferable valuation and earnings, ACAD or ASND? ACADIA Pharmaceuticals has higher revenue and earnings than Ascendis Pharma A/S. Ascendis Pharma A/S is trading at a lower price-to-earnings ratio than ACADIA Pharmaceuticals, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioACADIA Pharmaceuticals$1.02B3.44$226.45M$1.3315.60Ascendis Pharma A/S$393.54M32.75-$409.12M-$5.16-40.48 Is ACAD or ASND more profitable? ACADIA Pharmaceuticals has a net margin of 21.80% compared to Ascendis Pharma A/S's net margin of -54.94%. ACADIA Pharmaceuticals' return on equity of 14.69% beat Ascendis Pharma A/S's return on equity.Company Net Margins Return on Equity Return on Assets ACADIA Pharmaceuticals21.80% 14.69% 9.41% Ascendis Pharma A/S -54.94%N/A -24.31% Does the media favor ACAD or ASND? In the previous week, Ascendis Pharma A/S had 3 more articles in the media than ACADIA Pharmaceuticals. MarketBeat recorded 13 mentions for Ascendis Pharma A/S and 10 mentions for ACADIA Pharmaceuticals. Ascendis Pharma A/S's average media sentiment score of 0.61 beat ACADIA Pharmaceuticals' score of 0.24 indicating that Ascendis Pharma A/S is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment ACADIA Pharmaceuticals 1 Very Positive mention(s) 1 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Neutral Ascendis Pharma A/S 6 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Positive Do institutionals & insiders hold more shares of ACAD or ASND? 96.7% of ACADIA Pharmaceuticals shares are owned by institutional investors. 26.5% of ACADIA Pharmaceuticals shares are owned by insiders. Comparatively, 40.0% of Ascendis Pharma A/S shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth. SummaryACADIA Pharmaceuticals beats Ascendis Pharma A/S on 11 of the 17 factors compared between the two stocks. Get ACADIA Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for ACAD and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding ACAD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ACAD vs. The Competition Export to ExcelMetricACADIA PharmaceuticalsMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$3.50B$3.38B$6.14B$10.45BDividend YieldN/A2.30%5.73%4.78%P/E Ratio15.5922.9585.0627.10Price / Sales3.44428.48570.65176.64Price / Cash28.8946.1137.3961.86Price / Book4.7110.4812.406.66Net Income$226.45M-$52.47M$3.32B$276.79M7 Day Performance0.56%-0.91%-0.23%-1.40%1 Month Performance-13.42%14.63%9.56%5.64%1 Year Performance37.93%14.38%71.76%37.04% ACADIA Pharmaceuticals Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ACADACADIA Pharmaceuticals4.435 of 5 stars$20.52-5.6%$29.12+41.9%+45.8%$3.47B$1.02B15.45510Analyst ForecastASNDAscendis Pharma A/S3.105 of 5 stars$210.83+3.3%$244.36+15.9%+62.7%$12.57B$490.75M-40.861,017News CoverageAnalyst ForecastAnalyst RevisionGap UpVTRSViatris2.2316 of 5 stars$10.13-0.6%$10.40+2.7%-15.7%$11.81B$14.74B-3.4932,000News CoverageAnalyst ForecastRDYDr. Reddy's Laboratories2.828 of 5 stars$14.12-0.3%$16.95+20.0%-11.0%$11.79B$334.26B21.3927,811News CoverageROIVRoivant Sciences3.0242 of 5 stars$16.26+0.6%$19.94+22.6%+43.0%$11.10B$23.23M-23.23860Insider TradeMRNAModerna4.2566 of 5 stars$27.54-3.3%$41.81+51.8%-51.6%$10.72B$3.24B-3.665,800QGENQiagen4.2586 of 5 stars$46.99+0.4%$49.40+5.1%+11.5%$10.45B$1.98B27.765,765BBIOBridgeBio Pharma4.3037 of 5 stars$54.61+3.3%$63.94+17.1%+123.1%$10.44B$221.90M-13.35400Analyst RevisionELANElanco Animal Health2.7807 of 5 stars$20.68+0.2%$18.33-11.3%+47.1%$10.27B$4.44B24.059,000Analyst RevisionVRNAVerona Pharma PLC American Depositary Share1.4602 of 5 stars$106.91+0.1%$109.00+2.0%N/A$9.21B$42.28M-107.9930Positive NewsRVMDRevolution Medicines4.2591 of 5 stars$46.58-0.3%$74.64+60.2%+1.2%$8.71B$11.58M-10.35250Analyst ForecastInsider Trade Related Companies and Tools Related Companies Ascendis Pharma A/S Alternatives Viatris Alternatives Dr. Reddy's Laboratories Alternatives Roivant Sciences Alternatives Moderna Alternatives Qiagen Alternatives BridgeBio Pharma Alternatives Elanco Animal Health Alternatives Verona Pharma PLC American Depositary Share Alternatives Revolution Medicines Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:ACAD) was last updated on 10/16/2025 by MarketBeat.com Staff From Our PartnersURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredOctober 16 Changes the Microchip Game — and InvestingWhile everyone's chasing the same AI plays, George Gilder is focused on something completely different. He ...Banyan Hill Publishing | SponsoredBuilding The Infrastructure for the Coming Financial ResetWhile China pushes nearly $1 trillion through its new digital currency, one emerging company is quietly buildi...Intellistake | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredShots officially fired…Elon Musk just declared war on the wireless giants with a $17 billion spectrum deal that gives SpaceX the righ...Brownstone Research | SponsoredOptions Pro Reveals His #1 Retirement Income TradeIf you can be at your computer between 9 a.m. and 10:45 a.m. on most weekdays, I’ll show you a simple trading ...Base Camp Trading | SponsoredNEW LAW: Congress Approves Setup For Digital Dollar?Trump Ally Says Congress Approved the Setup for a Digital Dollar 2.0 But according to Rep. Marjorie Taylor ...Goldco Precious Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ACADIA Pharmaceuticals Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share ACADIA Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
